Sarah M Lofgren

Sarah M. Lofgren serves as an Assistant Professor in the Department of Medicine at the University of Minnesota School of Medicine, specializing in Infectious Disease and International Medicine. Her research focuses on HIV-related complications, particularly cryptococcal meningitis, with extensive field work conducted in Uganda.

Dr. Lofgren's research interests span multiple critical areas in global infectious disease research. Her primary focus is on HIV-associated complications, particularly cryptococcal meningitis and its neurological consequences. She investigates the intersection of HIV, neuroinflammation, and mental health, with particular attention to biomarkers in cerebrospinal fluid. Her work in Uganda examines healthcare delivery systems, gender disparities in HIV care access, and the impact of pandemics like COVID-19 on mental health services in resource-limited settings.

Analysis of Dr. Lofgren's publication record reveals a strong focus on HIV-related neurological complications, particularly cryptococcal meningitis. Her research consistently examines cerebrospinal fluid biomarkers, sex-specific differences in disease presentation, and mental health outcomes in HIV-positive populations. There's a clear trajectory from clinical epidemiology toward mechanistic studies of neuroinflammation and depression in HIV patients, with increasing emphasis on translational research that can inform treatment strategies in both resource-limited and developed settings.

Dr. Lofgren has secured significant research funding from the National Institute of Mental Health, including two major projects:

• "Neurotrophic Factor Signaling in the Pathogenesis of HIV-associated Depression: Cohort and Mechanistic Studies" (2021-2025)
• "Neuroinflammation and Modulating Factors in Depression and HIV" (2019-2024)

These projects reflect her growing expertise at the intersection of infectious disease, neurology, and mental health. She has also contributed to media discussions during the COVID-19 pandemic, providing expert commentary on resurgence risks and hydroxychloroquine trials.

While specific laboratory details aren't provided in the available information, Dr. Lofgren's research involves extensive collaboration with Ugandan institutions and researchers, suggesting a strong international research team structure. Her work appears to integrate clinical research, biomarker analysis, and mental health assessments, indicating a multidisciplinary approach to studying HIV complications in resource-limited settings.